Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2020.04.07.030767: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources We first used the BioJupies platform (https://amp.pharm.mssm.edu/biojupies/)32 to identify the differentially expressed genes (DEG) in lung samples during aging. BioJupiessuggested: (BioJupies, RRID:SCR_016346)The expression of HAPLN2 and TRIB3 (TMM normalized; V8 cohort) were compared using One-way ANOVA followed by Dunnett’s multiple comparisons test, with the GraphPad Prism version 6.00 for Windows (GraphPad Software, La Jolla, California, USA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for …
SciScore for 10.1101/2020.04.07.030767: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources We first used the BioJupies platform (https://amp.pharm.mssm.edu/biojupies/)32 to identify the differentially expressed genes (DEG) in lung samples during aging. BioJupiessuggested: (BioJupies, RRID:SCR_016346)The expression of HAPLN2 and TRIB3 (TMM normalized; V8 cohort) were compared using One-way ANOVA followed by Dunnett’s multiple comparisons test, with the GraphPad Prism version 6.00 for Windows (GraphPad Software, La Jolla, California, USA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on pages 17 and 14. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-